| abstract |
The invention relates to a pharmaceutical composition comprising sucralphate and mesalazine, and formulated as a gel, cream, enema, or rectal suppository. The use of this formulation is for the treatment of diseases such as actinic proctitis, diversion proctitis, aphthoid lesions of the rectum caused by avitaminosis or viruses, rhagades, fistulizing lesions, solitary ulcer of the rectum, haemorrhoids, anal itching. Other possible applications relate to the use in the treatment of rectal lesions caused by endoscopic dilatation, lesions of the rectum caused by radiotherapy or chemotherapy. |